PACS Group (PACS) saw its stock price surge by 18.19% in intraday trading on Wednesday, following the release of its third-quarter financial results and positive outlook for the full year. The healthcare operations company reported impressive figures that have evidently boosted investor confidence.

According to the company's latest financial report, PACS Group expects full-year revenue to be in the range of $5.3 billion to $5.4 billion. Additionally, the adjusted EBITDA is projected to fall between $480 million and $490 million. These strong financial projections, coupled with the company's successful completion of restating previous financial statements and becoming current with SEC filing obligations, likely contributed to the significant stock price increase.

PACS Group also highlighted its expanding portfolio, which now includes 320 healthcare operations across 17 states. The company owns 51 facilities outright and holds purchase options on an additional 59 facilities. This growth strategy, combining leasing, acquisitions, and evaluating opportunities in both high-performing and underperforming operations, seems to have resonated well with investors. As PACS Group continues to pursue expansion in the healthcare sector, today's stock surge suggests that the market is optimistic about the company's future prospects and financial health.